The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the ...

The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.

The BPDCN cell of origin is the plasmacytoid dendritic cell (pDC) precursor. The diagnosis of BPDCN is based on the immunophenotypic diagnostic triad of CD123, CD4, and CD56, as well as other markers.

An expert discusses how medical professionals have integrated tagraxofusp into blastic plasmacytoid dendritic cell neoplasm ...

Mattamy Homes, the largest privately owned homebuilder in North America, is pleased to announce the acquisition of 4.1 acres of prime real estate in the established master-planned community of Rocking ...

Today, the Government of Canada announced more than $40 million in contributions and low-cost repayable loans to build and repair 149 homes through eight housing projects located in Northern ...

An expert discusses how, historically, blastic plasmacytoid dendritic cell neoplasm (BPDCN) was treated with regimens for ...

The software provides a database of clinical images to help healthcare professionals diagnose skin conditions. Credit: Evgeniy Kalinovskiy/Shutterstock. The Menarini ...